Ronald McGarry, MD, PhD

Connect

(859) 257-7618
Ronald.McGarry@uky.edu

Chandler Medical Center, Room C114C, Pavilion H

Positions

Professor
Vice-Chairman for Research
Director of Body Radiosurgery Program

College Unit(s)

Radiation Medicine

Other Affiliation(s)

Radiation Medicine - Physicians

Biography and Education

Biography

Ronald C. McGarry, MD, PhD, is a clinical professor in the Department of Radiation Medicine at the University of Kentucky. Prior to arriving at UK in 2006, he served as professor for the Departments of Radiation Oncology at Indiana University and the University of Nebraska Medical Center and within the Department of Paediatrics at the University of Calgary in Canada. Dr. McGarry completed his residency in radiation oncology at the University of Western Ontario London Regional Cancer Center and he interned at McMaster University—both in Canada. He earned his BSc and MSc in zoology and his PhD in microbiology/immunology from the University of Western Ontario and his MD from the University of Calgary. Certified in radiation oncology by the American Board of Radiology and in Gamma Knife technology, Dr. McGarry has immense experience in the field as one of the pioneers of stereotactic body radiation therapy in the United States. He has been a part of several important research groups and presented on the results across the world during his more than 35-year career. His clinical interests include lung cancer, lymphoma, melanoma, skin cancer, and stereotactic radiotherapy. Outside of work, Dr. McGarry enjoys clay target shooting, photography, and traveling. Personal Statement: “To be able to effectively treat a tumor with stereotactic radiation therapy, you have to be very precise—within a millimeter of accuracy. It has to be done correctly, and requires QA and experience, which we have a lot of at UK. And I consider myself a perfectionist when it comes to this. I want to make sure to get the best outcomes with the fewest side effects for my patients.”

Education

M.D., University of Calgary, 1992

Ph.D., University of Western Ontario, 1981

M.Sc., University of Western Ontario, 1977

B.SC., Univesity of Western Ontario, 1975

Board Certification:

American Board of Radiology, Radiation Oncology, 1999

Selected Publications

BOOK CHAPTERS, REVIEWS McGarry, R.C. Extracranial stereotactic body radiotherapy in the management of early stage non-small cell lung cancer: a case study. In: Stereotactic Body Radiation Therapy (Kavanaugh, B. and Timmerman, R.,eds. ) Lippincott, Williams and Wilkins, pp. 110-113. 2005 Turrisi, D. and McGarry, R.C. Lung Cancer. in Handbook of Radiation Oncology: Basic Principles and Clinical Protocols. (Haffty, R.G. and Wilson, L. eds). Jones and Bartlett, Boston. Chapter 18 2008. McGarry, R. C. 2007. Stereotactic Body Radiation Therapy in the Treatment of Early Stage Lung Cancer. In Treating Tumors that Move with Respiration. (Urschel, H.C. ed) Robotic Radiosurgery, Springer-Verlag. pp117-124. McGarry, R. C. Local Control in Stage III Non-Small Cell Lung Cancer : Quo Vadis? Commentary. Am. J. Hem./Oncol. 6(9): 513-515. 2008. Lo, S.S., Cardenes, H.R., The, B.S., Fakiris, A.J., Papiez, L., McGarry, R. C., Wang, J.Z. et al. Stereotactic Body Radiation Therapy for Nonpulmonary Primary Tumors. Exp. Review in Anticancer Ther. 8(12):1939-51. 2008. Lo, S.L., Fakiris, A.J., Papiez, L., Abduhlrahman, R., McGarry, R.C., Henderson, M.A, Forquer, J.A., Hoopes, D., Timmerman, R.T. Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer. Expert Rev. in Anticancer Ther.. Jan; 8(1): 87-98. 2008. McGarry, R. C. Spine Radiosurgery. Eds Gerszten, P. and Ryu, S. IJROBP Invited book review. 74(2): 653. 2009. Tuanquin, L.C. and McGarry, R.C. Relapsed or Refractory Hodgkin’s Lymphoma: Dilemmas in Balancing the Risks and Benefits of Therapeutic Modalities Commentary. Am. J. Hem./Oncol. 8(7) 342-350. 2009. Shah, P.H. and McGarry, R.C. Adjuvant Chemotherapy for Stage IB Non-small Cell Lung Cancer: A Conundrum. Am. J. Hem./Oncol. 8(10): 497-499. 2009. Forquer, J.A., Fakiris, A.J., McGarry, R.C., Lo, S.S., Watson, C., Harkenrider, M., Henderson, M.A., and Johnstone, P.A.S. Treatment Options for Stage I Non-Small Cell Lung Carcinoma Patients Not Suitable for Lobectomy. Expert Rev. in Anticancer Ther. 9(10):1443-53, 2009. Lo, S.S., Fakiris, A.J., Teh, B.S., Cardenes, H. R., Henderson, M.A., Forquer, J.A., Papiez, L., McGarry, R.C., Wang, J.Z., Li, K., Mayer, N.A., Timmerman, R.D. Stereotactic Body Radiation Therapy for Oligometastases. 9(5): 621-35. 2009. Lo, S.S., Fakiris, A.J., Chang, E.L., Mayer, N.A., Wang, J.Z., Papiez, L., Teh, B.S., McGarry, R.C., Cardenes, H. R., Timmerman, R.D., Stereotactic Body Radiation Therapy: A Novel Cancer Treatment Modality. Nature Reviews, Clinical Oncology, 7:44-54. 2010 PUBLISHED ARTICLES McGarry, R.C., Papiez, L., Williams, M., Whitford, T., and Timmerman, R.T., Stereotactic Body Radiation Therapy of Early Stage Non-small Cell Lung Carcinoma: Phase I Study. Int. J. Rad. Oncol. Biol. Phys. 63(4): 1010-1015. 2005. Sinha, B. and McGarry, R. C. Extracranial stereotactic body radiation therapy in the management of bilateral pulmonary cancer. Int. J. Rad. Oncol. Biol. Phys. 66(4):1120-1124. 2006. Kavanagh, B.D., McGarry, R.C. and Timmerman, R.D Extracranial Radiosurgery (aka Stereotactic Body Radiation Therapy) for Oligometastases. Sem. Rad. Oncol. 16(2):77-84, 2006. Timmerman R., McGarry, R.C., Yiannoutsos, C., Ewing, M., Papiez, L., Tudor, K., DeLuca, J., Ewing, M., Abdulrahman, R., DesRosiers, C., Williams, M., and Fletcher, J. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J. Clin. Oncol. 24(30):4833-4839. 2006. Xu, Y.-H., Jagtap, M.R., Zhang, D.-B., Ying, J., McGarry, R.C., Mendonca, M.S., McLennan, G.. Kinetics of iododeoxyuridine release from sodium alginate hydrogel in vitro Journal of Interventional Radiology 15 (5), pp. 293-298. 2006. Xu, Y., Jagtap, M.R., Garland, T., McGarry, R.C., Mendonca, M.S. and McLennan, G. Iododeoxyuridine (IudR) uptake in Proliferating Smooth Muscle Cells. J. Vasc. Intervent. Radiol. 18(1 Pt 1): 73-8. 2007 L.Berk, L., Berkey, B., Rich, T., Hrushesky, W., Blask, D., Gallagher, M., Kudrimoti, M., McGarry, R.C., Suh, J. and Mehta, M. A Randomized Phase II Trial of High Dose Melatonin and Radiation Therapy for RPA Class 2 Patients with Brain Metastases (RTOG 0119). Int.J. Radiat. Oncol. Biol. Phys. Jul 1; 68(3): 673-81. 2007 Hoopes, D.J., Tann, M., Fletcher, J., Forquer, J.A., Lin, P., Lo, S., Timmerman, R. and McGarry, R.C. FDG-PET and Stereotactic Body Radiotherapy (SBRT) for Stage I Non-Small-Cell Lung Cancer. Lung Cancer 56:229-234. 2007. Tnnel, B., McGarry, R.C., Mendonca, M.S., Cummings, O., Chin-Sinex, H., Timmerman, R.D. Pulmonary Hilar Stereotactic Body Radiation Therapy in the Rat. TCRT. 6(5): 424-432. 2007. Hanna N., Neubauer M., McGarry R., et al. Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023. J. Thorac. Oncol; 2:8 (abstract B5-01). (Reviewed abstract). 2008. Hanna, N., Neubauer, M., Yiannoutsos, C. McGarry, R., Arseneau, J., Ansari, R., Reynolds, C., Govindan, R., Melnyk, A., Fisher, W., Richards, D., Bruetman, D., Anderson, T., Chowhan, N., Nattam, S., Mantravadi, P., Johnson, C., Breen, T., White,A., Einhorn, L. Cisplatin plus etoposide plus concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small cell lung cancer (NSCLC): a randomized phase III study from the Hoosier Oncology Group and U.S. Oncology. JCO. 26:5755-5760. 2008. Henderson, M; McGarry, R; Yiannoutsos, C; Fakiris, A; Hoopes, D; Williams, M; Timmerman, R. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. Oct 1; 72(2): 404-409. 2008 Fakiris, A.J., McGarry, R.C., Yiannoutsos, C., Papiez, L., Williams, M., Henderson, M.A., Timmerman, R. Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Carcinoma: 4 Year Results of a Prospective Phase II Study. Int.J. Radiat. Oncol. Biol. Phys.75(3):677-682. 2009. Forquer, J.A., Fakiris, A.J., Timmerman, R.D., Lo, S.S., Perkins, S.M., McGarry, R.C., Johnstone, P.A.S. Brachial Plexopathy from Stereotactic Body Radiotherapy in Early Stage NSCLC: Dose-Limiting Toxicity in Apical Tumor Sites. Radiotherapy & Oncology. 93(3):408-13, 2009 Henderson, M.A, Hoopes, D., Fletcher, J. , Lin, P. , Tann, M., Yiannoutsos, C.T., Williams, M., Fakiris, A.J., McGarry, R.C., Timmerman, R.. A Pilot Trial of Serial FDG-PET in Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer Treated with Hypofractionated Stereotactic Body Radiotherapy (SBRT). Int.J. Radiat. Oncol. Biol. Phys. 76(3):789-795. 2010. J. Feddock, R. McGarry. “Safety and Toxicity of Linac-based Stereotactic Body Radiotherapy (SBRT) Boost to Residual Disease in Locally Advanced Non-small Cell Lung Cancer: Preliminary Results of a Single Institution Feasibility Study.” Int J Rad. Oncol. Biol.Physics 78 (Suppl 1):S108, Abstract #231, 2010. (ASTRO Oral Presentation) Barriger, R.B., Fakiris, A.J., Hanna, N., Menggang, Y., Montravadi, P. and McGarry, R.C. “Dose-Volume Analysis of Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated With Concurrent Cisplatinum and Etoposide With or Without Consolidation Docetaxel.” Int. J. Rad. Oncol. Biol. Physics 78(5): 1381-1386, 2010.